St Vincent's Hospital, Sydney
Clinical trials sponsored by St Vincent's Hospital, Sydney, explained in plain language.
-
Hormone plus chemo combo aims to outsmart resistant prostate cancer
Disease control Recruiting nowThis study tests whether giving high-dose testosterone along with the chemotherapy drug carboplatin can help men whose advanced prostate cancer has stopped responding to standard hormone therapy. About 30 men with a specific genetic mutation (HRD) will receive the treatment. The …
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New combo therapy aims to boost immune attack on eye cancer
Disease control Recruiting nowThis early-stage trial tests whether adding a new drug, roginolisib, to the standard treatment tebentafusp is safe and tolerable for people with advanced uveal melanoma, a rare eye cancer. The study enrolls 8 adults whose cancer has spread and who are already on tebentafusp. The …
Phase: PHASE1 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC